Real-World Comparative Efficacy and Safety of Upadacitinib, Tofacitinib, and Filgotinib in Patients With Ulcerative Colitis
Cureus · 22.01.2026
DOI: 10.7759/cureus.102069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 22.01.2026. Verfasst von Fraz Ahmad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Royal Blackburn Hospital, Blackburn, GBR. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology and Hepatology, Royal Blackburn Hospital, Blackburn, GBR.
- Internal Medicine, East Lancashire Hospitals NHS Trust, Blackburn, GBR.
- Gastroenterology and Hepatology, East Lancashire Hospitals NHS Trust, Blackburn, GBR.
Zitieren
APA
Ahmad, F., Hussain, T., Gunaratne, C. H., Collum, J., Ghaffar, A., & Gharbia, K. (2026). Real-World Comparative Efficacy and Safety of Upadacitinib, Tofacitinib, and Filgotinib in Patients With Ulcerative Colitis. Cureus. https://doi.org/10.7759/cureus.102069
Vancouver
Ahmad F, Hussain T, Gunaratne CH, Collum J, Ghaffar A, Gharbia K. Real-World Comparative Efficacy and Safety of Upadacitinib, Tofacitinib, and Filgotinib in Patients With Ulcerative Colitis. Cureus. 2026. doi:10.7759/cureus.102069
BibTeX
@article{Ahmad2026,
author = {Ahmad, Fraz and Hussain, Tausif and Gunaratne, Chamith H and Collum, Joseph and Ghaffar, Abdul and Gharbia, Khaled},
title = {Real-World Comparative Efficacy and Safety of Upadacitinib, Tofacitinib, and Filgotinib in Patients With Ulcerative Colitis},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.102069}
}
EUVIMED